Skip to main content

Table 3 Antibiotics resistance patterns of GPB, HUCSH, and Southern Ethiopia

From: The burden of antimicrobial resistance at tertiary care hospital, southern Ethiopia: a three years’ retrospective study

Antibiotics

S. aureus (156)

CoNS (64)

Enterococcus spp(31)

S. pneumoniae (7)

Total

R (%)

R (%)

R (%)

R (%)

R (%)

AMP

NR

NR

20(74.1)

NR

20(74.1)

GEN

42(31.8)

32(55.2)

NR

NR

74(38.9)

COT

61(73.5)

49(90.7)

NR

4(66.7)

116(81.1)

PEN

41(80.4)

24(92.3)

6(75)

1(33.3)

72(81.8)

CAF

22(19.5)

22(40.7)

8(34.8)

3(60)

55(28.2)

CLD

2(5.3)

ND

NR

NR

2(5.3)

NOR

15(65.2)

3(33.3)

10(83.3)

NR

28(63.6)

NIT

1(14.3)

ND

1(12.5)

NR

2(13.3)

ERY

20(31.7)

9(50)

11(73.3)

0(0)

40(40.4)

TAT

11(61.1)

ND

3(100)

0(0)

14(63.6)

CIP

42(31.8)

27(46.6)

19(76)

NR

88(40.9)

AUG

51(52)

24(39.3)

NR

NR

75(47.2)

CTR

39(45.3)

22(41.5)

NR

NR

61(43.9)

CAZ

27(58.7)

31(79.5)

NR

ND

58(68.2)

  1. NR- Not recommended, ND-not done, R-Resistance, T- total tested, CoNS- coagulase-negative staphylococcus, ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg), penicillin G-PEN(10 IU), Clindamycin-CLD(2 μg) and erythromycin-ERY(15 μg).